Disclaimer: The views and opinions expressed in the articles contained in the Academy News are those of the identified authors and do not necessarily reflect the official policy or position of the Academy.
The United States Department of Justice (Department), Office of Justice Programs (OJP), Bureau of Justice Assistance (BJA) is seeking applications to plan and implement comprehensive programs in response to the growing opioid epidemic. This program furthers the Department’s mission by providing resources to support state, local, tribal, and territorial efforts to reduce violent crime and drug abuse and enhance public safety while supporting victims.
Applications Due: June 5, 2019
Click HERE for Grant Announcement.
About the Comprehensive Opioid Abuse Site-Based Grant Program (COAP):
Signed into law on July 22, 2016, the Comprehensive Addiction and Recovery Act (CARA) is the first major federal substance abuse treatment and recovery legislation in 40 years and the most comprehensive legislative effort to address the opioid epidemic. CARA establishes a comprehensive, coordinated, and balanced strategy through enhanced grant programs that encompass prevention and education efforts, effective responses to those affected by substance abuse, and services for treatment and recovery from addiction. For FY 2019, in recognition of the ongoing national opioid priority, Congress has appropriated $157 million in support of CARA-related programs and $30 million in support of Prescription Drug Monitoring Programs (PDMPs).
BJA developed the COAP in response to the CARA legislation. COAP’s purpose is to provide financial and technical assistance to states, units of local government, and Indian tribal governments to plan, develop, and implement comprehensive efforts to identify, respond to, treat, and support those impacted by the opioid epidemic. Since 2017, the Harold Rogers Prescription Drug Monitoring Program (PDMP) has been incorporated into COAP, emphasizing the important role that PDMPs play in supporting safe prescribing and in identifying patients who may be misusing prescription opioids (or other prescription drugs) and/or patients who may be at risk for overdose.
Learn more about the Comprehensive Opioid Abuse Site-based FY 2019 Competitive Grant and application process during the upcoming webinar on April 29, 2019, at 2:00 p.m., ET.
About COAP Awards and the Webinar
In this webinar, BJA leaders will review the FY 2019 COAP grant application process. This site-based grant program provides awards ranging from $600,000 to $6,500,000 for a 36-month project period to deliver financial and technical assistance to states, units of local government, and Indian tribal governments to plan, develop, and implement comprehensive efforts to identify, respond to, treat, and support those impacted by the opioid epidemic.
There are three award categories:
- Category 1: Locally Driven Responses to the Opioid Epidemic—Funding amount: $600,000—$1,200,000
- Category 2: Statewide Implementation, Enhancement, and Evaluation Projects—Funding amount: $3,000,000—$6,500,000
- Category 3: Harold Rogers Prescription Drug Monitoring Program (PDMP) Implementation and Enhancement Projects—Funding amount: up to $2,000,000
- Tara Kunkel, M.S.W., Senior Drug Policy Advisor, BJA
- Tim Jeffries, M.S.W., Senior Drug Policy Advisor, BJA
Learn more about COAP at www.coapresources.org.
This webinar will be recorded for future reference and sharing with colleagues who are unable to attend. Please email COAP@iir.com for more information or if you encounter trouble registering.